Due to growing life expectancy and unhealthy lifestyles, dementia is a fast growing chronic disease that affects the behaviour and communication abilities of people living with this neurological disorder. Caregivers are often challenged by this fact, which could lead to stress, helplessness, aggressive situations and caregiver burnout. The SUCCESS project provides an innovative mobile training application to support formal and informal caregivers to appropriately interact with people with dementia. The application provides evidence-based communication and intervention strategies and guides the user to effectively respond to specific situations in dementia care.
To support caregivers in their interaction with persons with dementia.
Formal and informal caregivers that have contact with persons with dementia.
Impact for citizen
The user will learn how to interact with the people they care for. It guides the user to effectively respond to specific situations in dementia care and also provides strategies for emotional support as to help carers to keep balance between care responsibilities and personal needs.
Impact for staff
Formal caregivers are often not trained to handle the specific needs of persons with dementia. SUCCESS helps them to easily learn about the specific needs.
We foresee two possible approaches. One the one hand as standalone app offered through the market place and on the other hand as trainings app for all kind of care organizations who can then offer it to their formal or informal caregivers.
Cost of product
Life expectancy of product
Other costs of acquisition and setup
Expected annual costs
~36 € per year.
Is the product for personal use or can it be used by (how) many people?
Is the product intended for training purposes?
How much time is needed for the user or staff to get to know how to use of the product?
It is self-explanatory – about 10 minutes.
Has the product been presented before at other exhibitions or venues?
AAL Forum 2018 (from other project partner).
Experiences from practice (examples)
Field Trials at the moment.